These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 19142181)

  • 1. Striatal readministration of rAAV vectors reveals an immune response against AAV2 capsids that can be circumvented.
    Peden CS; Manfredsson FP; Reimsnider SK; Poirier AE; Burger C; Muzyczka N; Mandel RJ
    Mol Ther; 2009 Mar; 17(3):524-37. PubMed ID: 19142181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain.
    Peden CS; Burger C; Muzyczka N; Mandel RJ
    J Virol; 2004 Jun; 78(12):6344-59. PubMed ID: 15163728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time course of transgene expression after intrastriatal pseudotyped rAAV2/1, rAAV2/2, rAAV2/5, and rAAV2/8 transduction in the rat.
    Reimsnider S; Manfredsson FP; Muzyczka N; Mandel RJ
    Mol Ther; 2007 Aug; 15(8):1504-11. PubMed ID: 17565350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient immunosuppression allows transgene expression following readministration of adeno-associated viral vectors.
    Manning WC; Zhou S; Bland MP; Escobedo JA; Dwarki V
    Hum Gene Ther; 1998 Mar; 9(4):477-85. PubMed ID: 9525309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system.
    Burger C; Gorbatyuk OS; Velardo MJ; Peden CS; Williams P; Zolotukhin S; Reier PJ; Mandel RJ; Muzyczka N
    Mol Ther; 2004 Aug; 10(2):302-17. PubMed ID: 15294177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential.
    Li Q; Miller R; Han PY; Pang J; Dinculescu A; Chiodo V; Hauswirth WW
    Mol Vis; 2008 Sep; 14():1760-9. PubMed ID: 18836574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential transgene expression profiles in rat brain, using rAAV2/1 vectors with tetracycline-inducible and cytomegalovirus promoters.
    Bockstael O; Chtarto A; Wakkinen J; Yang X; Melas C; Levivier M; Brotchi J; Tenenbaum L
    Hum Gene Ther; 2008 Nov; 19(11):1293-305. PubMed ID: 19866492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transduction of pancreatic islets with pseudotyped adeno-associated virus: effect of viral capsid and genome conversion.
    Zhang N; Clément N; Chen D; Fu S; Zhang H; Rebollo P; Linden RM; Bromberg JS
    Transplantation; 2005 Sep; 80(5):683-90. PubMed ID: 16177645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilizing minimally purified secreted rAAV for rapid and cost-effective manipulation of gene expression in the CNS.
    Goodwin MS; Croft CL; Futch HS; Ryu D; Ceballos-Diaz C; Liu X; Paterno G; Mejia C; Deng D; Menezes K; Londono L; Arjona K; Parianos M; Truong V; Rostonics E; Hernandez A; Boye SL; Boye SE; Levites Y; Cruz PE; Golde TE
    Mol Neurodegener; 2020 Mar; 15(1):15. PubMed ID: 32122372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additional transduction events after subretinal readministration of recombinant adeno-associated virus.
    Anand V; Chirmule N; Fersh M; Maguire AM; Bennett J
    Hum Gene Ther; 2000 Feb; 11(3):449-57. PubMed ID: 10697119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant AAV serotype 1 transduction efficiency and tropism in the murine brain.
    Wang C; Wang CM; Clark KR; Sferra TJ
    Gene Ther; 2003 Aug; 10(17):1528-34. PubMed ID: 12900769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of melittin to enhance transgene expression mediated by recombinant adeno-associated virus serotype 2 vectors both in vitro and in vivo.
    Xie YL; Wang JY; He Y; Yu XM; Zheng QY; Ling C; Feng XL; Zhu LQ
    J Integr Med; 2023 Jan; 21(1):106-115. PubMed ID: 36333178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of recombinant adeno-associated viral vectors serotypes 1, 2, and 5 for the transduction of pancreatic and colon carcinoma cells.
    Teschendorf C; Emons B; Muzyczka N; Graeven U; Schmiegel W
    Anticancer Res; 2010 Jun; 30(6):1931-5. PubMed ID: 20651336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled delivery of glial cell line-derived neurotrophic factor by a single tetracycline-inducible AAV vector.
    Chtarto A; Yang X; Bockstael O; Melas C; Blum D; Lehtonen E; Abeloos L; Jaspar JM; Levivier M; Brotchi J; Velu T; Tenenbaum L
    Exp Neurol; 2007 Mar; 204(1):387-99. PubMed ID: 17223106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced transduction of mouse salivary glands with AAV5-based vectors.
    Katano H; Kok MR; Cotrim AP; Yamano S; Schmidt M; Afione S; Baum BJ; Chiorini JA
    Gene Ther; 2006 Apr; 13(7):594-601. PubMed ID: 16341060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated delivery of adeno-associated virus vectors to the rabbit airway.
    Beck SE; Jones LA; Chesnut K; Walsh SM; Reynolds TC; Carter BJ; Askin FB; Flotte TR; Guggino WB
    J Virol; 1999 Nov; 73(11):9446-55. PubMed ID: 10516053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of subretinal readministration of a viral vector in large animals to treat congenital blindness.
    Amado D; Mingozzi F; Hui D; Bennicelli JL; Wei Z; Chen Y; Bote E; Grant RL; Golden JA; Narfstrom K; Syed NA; Orlin SE; High KA; Maguire AM; Bennett J
    Sci Transl Med; 2010 Mar; 2(21):21ra16. PubMed ID: 20374996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tracking Adeno-Associated Virus Capsid Evolution by High-Throughput Sequencing.
    de Alencastro G; Pekrun K; Valdmanis P; Tiffany M; Xu J; Kay MA
    Hum Gene Ther; 2020 May; 31(9-10):553-564. PubMed ID: 32024384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection and evaluation of clinically relevant AAV variants in a xenograft liver model.
    Lisowski L; Dane AP; Chu K; Zhang Y; Cunningham SC; Wilson EM; Nygaard S; Grompe M; Alexander IE; Kay MA
    Nature; 2014 Feb; 506(7488):382-6. PubMed ID: 24390344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of rAAV2-mediated transgene expression in retina cells in vitro and in vivo by coadministration of low-dose chemotherapeutic drugs.
    Zhang S; Wu J; Wu X; Xu P; Tian Y; Yi M; Liu X; Dong X; Wolf F; Li C; Huang Q
    Invest Ophthalmol Vis Sci; 2012 May; 53(6):2675-84. PubMed ID: 22427581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.